Phosphatidylcholine.

Both are structural phospholipids of the cell membrane, and the body interconverts them by swapping the head group through base exchange. Supplying phosphatidylcholine feeds the same membrane phospholipid pool that phosphatidylserine is drawn from.

In membranes DHA sits mainly at the sn-2 position of phosphatidylcholine, and lysophosphatidylcholine is the form that carries DHA into neural tissue. Phosphatidylcholine provides the phospholipid backbone that DHA is built into rather than circulating free.

Choline released from phosphatidylcholine is oxidized to betaine, the same molecule as TMG, which then donates a methyl group to convert homocysteine back to methionine. The two draw on and refill the same methyl pool, so each spares the other's demand.

The body makes phosphatidylcholine from phosphatidylethanolamine by adding three methyl groups through the PEMT pathway, and SAM-e is the methyl donor for each of those steps. Endogenous phosphatidylcholine synthesis therefore consumes SAM-e as its methyl source.

Phosphatidylcholine is the main phospholipid form in which choline is carried and stored, and phospholipase hydrolysis releases free choline. Supplying either one feeds the same pool used for membranes and for acetylcholine synthesis.

Lecithin is the crude phospholipid fraction from soy or sunflower in which phosphatidylcholine is the largest component. Concentrated phosphatidylcholine and lecithin therefore deliver the same head group at different purities.

Alpha-GPC is the deacylated choline phospholipid and enters the same cytidine pathway that builds membrane phosphatidylcholine. Both raise the choline available for acetylcholine synthesis, by routes that meet at the same intermediate.

The liver can build phosphatidylcholine by methylating phosphatidylethanolamine three times, which consumes S-adenosylmethionine. Adequate folate regenerates methionine through the folate cycle, so less choline has to be oxidised for methyl groups.

B12 is the cofactor for methionine synthase, the step that turns homocysteine back into methionine for methyl donation. When that cycle runs well, choline and phosphatidylcholine are spared for structural use.

Long chain omega-3 fatty acids are esterified into the sn-2 position of phosphatidylcholine, which is how they end up in membranes. Supplying head group and acyl chain together matches what the membrane actually assembles.

In krill oil a large share of the EPA and DHA arrives bound to phosphatidylcholine rather than as triglycerides. The two ingredients describe the same delivery chemistry, with krill oil supplying both parts at once.

Phosphatidylcholine carrying polyunsaturated fatty acids is the main substrate for lipid peroxidation chains. Alpha-tocopherol sits in the same bilayer and stops that chain propagation, which is also why it is added to phospholipid raw materials.

Huperzine A slows acetylcholinesterase so released acetylcholine lingers, while phosphatidylcholine supplies the choline needed to build it. One side raises supply and the other slows breakdown.

Curcumin is poorly water soluble and is routinely formulated as a phosphatidylcholine complex, which raises the amount absorbed relative to unformulated powder. Here the phospholipid acts as the carrier chemistry rather than a second active.

Silybin is bound to phosphatidylcholine in phytosome raw materials to improve its passage across the intestinal membrane. The phospholipid changes how much of the flavonolignan is absorbed rather than what it does.

Inositol forms phosphatidylinositol, the signalling counterpart to phosphatidylcholine in the same bilayer. Supplying both head groups covers the structural and the signalling phospholipid pools.

CDP-choline is the activated intermediate in the Kennedy pathway, the step immediately before choline phosphotransferase transfers the phosphocholine head group onto diacylglycerol to make phosphatidylcholine. Supplying CDP-choline feeds the same endpoint from one step upstream. The two are points on one pathway rather than independent actives.

The second route to phosphatidylcholine is the PEMT pathway, in which phosphatidylethanolamine receives three methyl groups from S-adenosylmethionine. Methionine is the amino acid that becomes S-adenosylmethionine, so methionine supply sets the ceiling on that route. This is a substrate relationship established in liver biochemistry, not a combination trial result.

5-methyltetrahydrofolate donates the methyl group that regenerates methionine from homocysteine, restocking the S-adenosylmethionine pool that the PEMT route to phosphatidylcholine draws on. Choline and folate are partially interchangeable methyl sources, so low intake of one raises demand on the other. The relationship runs in both directions.

Methylenetetrahydrofolate reductase is a flavoprotein and requires FAD, made from riboflavin, to generate the 5-methyl folate that feeds methionine regeneration. Riboflavin status therefore sits upstream of the methyl supply that the PEMT route to phosphatidylcholine consumes. This is a cofactor dependency rather than a measured supplement interaction.

Bile salts and phosphatidylcholine together form the mixed micelles that carry dietary lipid to the intestinal brush border, and biliary phosphatidylcholine is itself a major component of bile. Supplemental bile components and phospholipid act on the same emulsification step. The pairing is digestive physiology, not a novel synergy.

Phosphatidylcholine is not absorbed intact in bulk; pancreatic phospholipase A2 removes the sn-2 fatty acid to give lysophosphatidylcholine, which is what enters the enterocyte and is re-acylated there. Digestive enzyme blends that carry phospholipase activity act directly on this step. Plain lipase alone acts on triglycerides rather than the phospholipid.

Pancreatin is a mixed pancreatic enzyme preparation that includes phospholipase A2 alongside lipase, amylase and proteases. That phospholipase activity is the specific one that converts dietary phosphatidylcholine into the absorbable lysophospholipid. The relevance is mechanistic and specific to the phospholipase fraction.

Coenzyme Q10 is a large, highly lipophilic quinone with poor aqueous dispersion, and phospholipid carriers are one of the standard ways it is delivered. Phosphatidylcholine forms the bilayer or mixed micelle that keeps the quinone dispersed until bile salts take over. The formulation logic is well established; the size of the absorption difference varies by preparation.

Astaxanthin is a xanthophyll carotenoid that requires a lipid phase to disperse and absorb. Phosphatidylcholine provides an amphiphilic interface that keeps it in suspension and feeds it into mixed micelles. The effect is a delivery one rather than a change in what the carotenoid does.

Carotenoid uptake depends on incorporation into mixed micelles, and phospholipids participate in forming those micelles alongside bile salts and fatty acids. Lutein delivered with a phospholipid carrier is dispersed before it reaches the gut lumen. The mechanism is dispersion and micellar transfer, not a change in retinal handling.

Cholecalciferol is a secosteroid absorbed through the same micellar route as dietary fat. Phosphatidylcholine contributes to micelle formation and is used as an emulsifier in liquid and softgel vitamin D preparations. This is formulation and physiology rather than a demonstrated increase in circulating levels from the pairing.

Menaquinone-7 is highly lipophilic and is absorbed with dietary lipid through mixed micelles. Phospholipid emulsifiers keep it dispersed in an oil or powder matrix. The relationship is a delivery one and its magnitude depends on the specific formulation.

Tocotrienols are lipophilic vitamin E isoforms with short unsaturated side chains that partition into membranes readily but need a lipid vehicle to reach them. Phosphatidylcholine serves as that vehicle and as a membrane target once absorbed. Read the pairing as delivery plus membrane incorporation.

Medium chain triglycerides are hydrolysed rapidly and absorbed with less dependence on micelle formation than long chain fats. Combined with phosphatidylcholine they give a lipid phase plus an emulsifier, which is a common way to disperse lipophilic actives. The two do different jobs within one delivery system.

Sunflower lecithin is the crude phospholipid mixture from which concentrated phosphatidylcholine is fractionated, and it contains phosphatidylcholine alongside phosphatidylethanolamine, phosphatidylinositol and residual oil. A product may declare either the lecithin or the fractionated phospholipid, and the phosphatidylcholine content differs greatly between them. Reading a lecithin quantity as a phosphatidylcholine quantity overstates the latter.

Plant sterols and phospholipids both act inside the mixed micelle, where sterols compete with cholesterol for micellar space and phospholipids shape the micelle itself. A 2026 report examined combined phytosterols and phospholipids against blood lipid measures and erythrocyte membrane composition. Those are markers of lipid handling and membrane makeup, not clinical outcomes.

Gut bacteria convert both choline, released from phosphatidylcholine, and carnitine into trimethylamine, which the liver oxidises to trimethylamine N-oxide. Taking both raises the substrate load on the same microbial route. An association between phosphatidylcholine intake and circulating trimethylamine N-oxide has been reported in middle-aged and older adults; that is an association between an intake and a marker, not a demonstrated outcome.

How much dietary choline becomes trimethylamine before absorption depends on which organisms carry the relevant lyase genes in a given gut community. Probiotic organisms are studied as modifiers of that community. Neither the direction nor the size of any change to choline handling is established, so this is a plausible interaction rather than a described effect.

Phosphatidylcholine from soy and sunflower is rich in linoleic acid, a polyunsaturated fatty acid vulnerable to peroxidation. Alpha-tocopherol sitting in the membrane intercepts that chain reaction and is regenerated from its radical form by ascorbate at the aqueous interface. Vitamin C therefore supports the antioxidant that protects the phospholipid, one step removed.

Taurine conjugates bile acids, and taurine-conjugated bile salts remain ionised across a wider pH range than glycine-conjugated ones, which affects micelle stability in the upper intestine. Phosphatidylcholine absorption depends on that micellar phase. The link is indirect and rests on bile chemistry rather than on a combination study.

Resveratrol has low aqueous solubility and heavy first-pass conjugation, and phospholipid complexation is one of the standard approaches used to disperse it. Phosphatidylcholine forms the complex through hydrogen bonding with the polyphenol's hydroxyl groups. The approach is well established in formulation work; per-product results differ.

Retinyl esters are hydrolysed in the intestinal lumen and the free retinol partitions into mixed micelles alongside phospholipid and bile salt. Phosphatidylcholine contributes to that micellar phase and is used as an emulsifier in oil-based preparations. The role is delivery.